About Hatteras Venture Partners
Hatteras Venture Partners is a venture capital firm founded in 2000. It is primarily based out of Durham, United States. As of Jun 2025, Hatteras Venture Partners is an active investor, having invested in 117 companies, with 2 new investments in the last 12 months. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Applications. Most recently it led the $8M Series C round of GeneCentric along with LabCorp. This round also saw participation from IAG Capital Partners and other investors.
Overall, Hatteras Venture Partners portfolio has seen 12 IPOs and 28 acquisitions including key companies like CVRx, Kymeratx and Nabriva. A lot of funds co-invest with Hatteras Venture Partners, with names like Alexandria sharing a substantial percentage of its portfolio.
Hatteras Venture Partners has team of 34 people including 6 partners.
Key Metrics
Team Members
, &
Portfolio Count
CVRx, &
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series B &
Portfolio IPOs
Portfolio Soonicorns
Deals in last 12 months
Hatteras Venture Partners' List of Top Investments
Hatteras Venture Partners has a portfolio of 117 companies. Their most notable investments are in Myeloid Therapeutics and Pathfinder Technologies.Their portfolio spans across United States, Switzerland, AustriaÌý²¹²Ô»å 7 more locations. They have invested in Life Sciences, High Tech, Enterprise ApplicationsÌý²¹²Ô»å 16 other sectors, across stages such as Series A, Series B Ìý²¹²Ô»å 7 more. Here is the list of top investments by Hatteras Venture Partners:1. CVRx
CVRx is a developer of implantable technology for hypertension and heart failure. The product Barostim neo is implanted under the skin, similar to a pacemaker. It then sends signals to the body's cardiovascular regulators to improve cardiac and vascular function by restoring sympathovagal balance through activation of the afferent and efferent pathways of the autonomic nervous system. The product is CE marked and approved for sale in Europe for both indications.
Key facts about CVRx
- Founded Year: 2001
- Location: Minneapolis (United States)
- Annual Revenue: $39.3M as on Dec 31, 2023
- Stage: Public
- Total Funding till date: $394M
- Employee Count: 142 as on Dec 31, 2022
- Investors: InterWest Partners, Frazier Healthcare Partners and 19 Others
- Latest Funding Round: Series F, Jul 07, 2020, $50M
- Highlight: Public
2.
Key facts about Elligo
- Founded Year: 2016
- Location: Austin (United States)
- Stage: Series E
- Total Funding till date: $176M
- Employee Count: 280 as on Dec 31, 2021
- Investors: Piper Jaffray, Morgan Stanley and
- Latest Funding Round: Venture Debt, Oct 03, 2023, $40M
- Highlight: Editors' Pick
3. Spiffy
Online platform to book on-demand car wash & detailing service. Users can select a location & time to book the service via their platform or app by making an online payment. Their service also includes oil changes, disinfection, tire change & more. The mobile application is available for iOS & Android devices.
Key facts about Spiffy
- Founded Year: 2014
- Location: Charlotte (United States)
- Stage: Series C
- Total Funding till date: $90.8M
- Employee Count: 129 as on Dec 31, 2022
- Investors: Industry Ventures, Hatteras Venture Partners and 27 Others
- Latest Funding Round: Series C, Feb 15, 2023, $30M
- Highlight: Editors' Pick
4. Kymeratx
Developer of small molecule protein degraders for multiple disorders. It offers small molecules to target IRAK4, IRAKIMiD, and STAT3, and has the potential to treat immune-inflammatory diseases, hematologic malignancies, and solid tumors. It offers targeted protein degradation platforms and functions on the principle of the ubiquitin-proteasome system, which plays an integral role in regulating cellular processes.
Key facts about Kymeratx
- Founded Year: 2016
- Location: Cambridge (United States)
- Stage: Public
- Total Funding till date: $197M
- Employee Count: 150 as on Dec 31, 2022
- Investors: Avoro Capital Advisors, Rock Springs Capital and 22 Others
- Latest Funding Round: Post IPO, Aug 19, 2022, $150M
- Highlight: Public
5.
On-demand nonemergency transport platform to healthcare organizations. The company's mobile app brings new business to non-emergency medical drivers who want to pick up on-demand rides. It responds to ride requests much like an Uber or Lyft experience. The company solutions also include tools to engage the patient (increasing adherence) and analytics to identify and triage "at risk" patients.
Key facts about Safe Ride Health
- Founded Year: 2015
- Location: Los Angeles (United States)
- Stage: Series C
- Total Funding till date: $39M
- Employee Count: 165 as on Dec 31, 2021
- Investors: New Enterprise Associates, SVB and
- Latest Funding Round: Series C, Oct 06, 2023, $36.3M
- Highlight: Editors' Pick
Hatteras Venture Partners' Year-on-Year Investment Trends
Hatteras Venture Partners has invested in 117 companies over the last 18 years, with an average of 4 new investments annually in the last 10 years. In 2024, it made 5 investments, while as of Jun 2025, it has made 3 investments in this year. Its most recent first time investment was in and most recent follow-on round was in GeneCentric.
Year | No. of Investments | ||
|---|---|---|---|
1stÌý¸é´Ç³Ü²Ô»å | Follow-on | Total | |
2025 (YTD) | 0 | 3 | 3 |
2024 | 4 | 1 | 5 |
2023 | 2 | 3 | 5 |
2022 | 6 | 3 | 9 |
2021 | 6 | 6 | 12 |
2020 | 7 | 2 | 9 |
2019 | 3 | 3 | 6 |
2018 | 5 | 4 | 9 |
2017 | 5 | 7 | 12 |
2016 | 2 | 1 | 3 |
Get Hatteras Venture Partners' portfolio delivered to your inbox!
Hatteras Venture Partners' Investments by Stage
Hatteras Venture Partners is primarily an Early Stage Investor investor majorly investing in Series A (35) rounds where average round size is $738M, Series B (14) rounds where average round size is $266M and Seed (7) rounds where average round size is $19.2M.Note: We have considered here, only first round of investments
Stage of entry | No. of Investments |
|---|---|
Series A | 35 |
Series B | 14 |
Seed | 7 |
Series C | 7 |
Series D | 2 |
Others | 4 |
Hatteras Venture Partners' Investments by Sector
Hatteras Venture Partners has a diverse portfolio, with companies operating in the Life Sciences, HealthTech, High Tech, Enterprise Applications and Sustainability Tech. Notably, it has invested in 99 Tech companies, 88 Enterprise (B2B) companies, 17 Software companies and at least 14 companies focusing on Consumer (B2C).
Note: We have considered here, only first round of investments
Sector | No. of Investments |
|---|---|
Life Sciences | 56 |
HealthTech | 13 |
High Tech | 13 |
Enterprise Applications | 9 |
Sustainability Tech | 9 |
Others | 18 |
Hatteras Venture Partners' Investments by Geography
Hatteras Venture Partners has made most investments in United States (66), followed by Canada where it has made 1 investment.
Note: We have considered here, only first round of investments
Country | No. of Investments |
|---|---|
United States | 66 |
Canada | 1 |
China | 1 |
Ireland | 1 |
Hatteras Venture Partners' recent investments
Here are the most recent investments by Hatteras Venture Partners:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jun 18, 2025 | United States | Series C | $8M | IAG Capital Partners [+2] | |
Mar 27, 2025 | United States | Series C | $150M | ||
Mar 17, 2025 | United States | Series B | $14M | Orlando Health [+6] | |
Oct 18, 2024 | United States | Series A | $115M | [+13] | |
Sep 06, 2024 | United States | Series C | $4M |
Get the detailed list of all investments by Hatteras Venture Partners. Download now!IPOs and Publicly Listed companies in Hatteras Venture Partners' Portfolio
Here are Hatteras Venture Partners' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Mar 25, 2022 | Jan 07, 2022 | Series B | $80M | |
Sep 24, 2021 | - | - | - | |
Jun 30, 2021 | Jul 07, 2020 | Series F | $50M | |
Oct 09, 2020 | Jun 19, 2020 | Series C | $83M | |
Aug 21, 2020 | Nov 13, 2018 | Series B | $65M |
Acquired companies in Hatteras Venture Partners' Portfolio
Here are Hatteras Venture Partners' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
May 21, 2025 | Dec 08, 2020 | Series A | $50M | |
Jan 27, 2025 | - | - | - | |
Jun 26, 2023 | - | - | - | |
Jun 25, 2023 | Jul 31, 2019 | Series A | $33M | |
Aug 23, 2022 | - | - | - |
Team profile of Hatteras Venture Partners
Hatteras Venture Partners has a team of 34 membersÌýincluding 6 Partners, 6 Venture Partners and 4 PrincipalsÌýlocated in United States and United Kingdom. Hatteras Venture Partners' team does not sit on the board of any company as of now.Here is a list of top team members in Hatteras Venture Partners:
Name | Designation | Location | Board Memberships | Contact details |
|---|---|---|---|---|
Partner | Durham | - | ||
Partner | Chapel Hill | - | - | |
Partner | Durham | - | ||
Partner | Durham | - | ||
Partner | Durham | - | ||
Partner | Chapel Hill | - | ||
Venture Partner | Durham | - | ||
Venture Partner | South Burlington | - | ||
Venture Partner | Durham | - | ||
Venture Partner | Washington, DC | - | - | |
Venture Partner | - | - | - |
Get the full list of Hatteras Venture Partners' team & partners for free. Download now!Co-investors of Hatteras Venture Partners
Over the past 18 years, 417 investors have co-invested in Hatteras Venture Partners's portfolio companies.
- Invested before Hatteras Venture Partners:ÌýHHS, New Enterprise Associates and 92 others have invested in rounds before Hatteras Venture Partners. There are 6 companies where HHS has invested before Hatteras Venture Partners and 3 companies where New Enterprise Associates has invested before Hatteras Venture Partners.
- Top Co-investors of Hatteras Venture Partners:Ìý183 investors entered a company along with Hatteras Venture Partners. These include investors like Alexandria (4 companies).
- Invested after Hatteras Venture Partners:ÌýA total of 140 investors have invested in Hatteras Venture Partners's portfolio after their investments. Top Investors include Rock Springs Capital (5 companies), Mountain Group Partners (4 companies) and HHS (4 companies).
Get full list of Hatteras Venture Partners' co-investors delivered to your inbox!
Recent News related to Hatteras Venture Partners
•
FinSMEs•Apr 04, 2025•Atsena Therapeutics, Bain Capital Life Sciences, Wellington, Lightstone Ventures and 6 others
•
Pharmaceutical Technology•Apr 03, 2025•Atsena Therapeutics, Bain Capital Life Sciences, Wellington, Lightstone Ventures and 3 others
•
•
Hypepotamus•Nov 18, 2024•Portal Innovations, Avanos, Rex Health Ventures, Hatteras Venture Partners
•
•
Asiaone•Jun 25, 2024•Endogenex, Hatteras Venture Partners, Lumira Ventures, Orlando Health and 5 others
•
G-MedTech•Apr 25, 2024•AtaCor Medical, Arboretum Ventures, Broadview Ventures, Hatteras Venture Partners and 2 others
•
G-MedTech•Apr 24, 2024•iVEAcare, Vensana Capital, Treo Ventures, Hatteras Venture Partners and 2 others
•
•
WRAL TechWire•Oct 02, 2023•Atsena Therapeutics, Hatteras Venture Partners, Lightstone Ventures, Sofinnova Investments
